Key Takeaways & Executive Findings
- ā¢ā¢ Rats, gerbils, guinea pigs, mice, and New Zealand rabbits are the most commonly used animal models for studying Chinese herbal compound treatment of intervertebral disc degeneration. ⢠The annulus fibrosus puncture model is the most widely used modeling method, but combined modeling approaches better mimic the disease progression. ⢠Oral administration is the predominant route for delivering Chinese herbal compounds in animal experiments, mirroring clinical practice. ⢠Therapeutic efficacy is typically assessed through imaging, behavioral tests, molecular biology, and histological analyses.
Abstract
BACKGROUND: Chinese herbal compound has a unique curative effect on lumbar disc degeneration. In order to further understand the mechanism of its action, researchers have carried out many animal experiments in vivo, but there is no agreement on the animal model, the way of administration and the choice of observation indicators. OBJECTIVE: To review the progress in animal experimental studies on the treatment of lumbar disc degeneration with Chinese herbal compounds, focusing on the preparation of animal models of lumbar disc degeneration, the administration methods of Chinese herbal compounds and the evaluation indexes of efficacy, in order to provide a reference for related studies. METHODS: CNKI, WanFang, VIP, PubMed and Web of Science were retrieved by computer for relevant literature published from database inception to November 2024. The Chinese terms were āChinese medicine, compound, Chinese medicine, herbal, drug combination, soup, formula, low back pain, degenerative disc disease, disc degeneration, intervertebral disc injury, animal, rat, mouse, rabbit, dog, pig, sheep, monkey, primate, model, modeling, experiment, research, progress, reviewā; the English terms were ātraditional Chinese medicine, Chinese herbal medicine, Chinese medicine formula, herbal formula, intervertebral disc degeneration, degenerative disc disease, disc degeneration, intervertebral disc injury, animal model, animal experiment, preclinical study, rat, mouse, rabbit, sheep, dog, pig, non-human primate, monkey, primate, treatment, therapy, effect, interventionā. A total of 789 relevant articles were retrieved, and 139 articles met the inclusion criteria. RESULTS AND CONCLUSION: (1) Researchers using Chinese herbal compounds to treat intervertebral disc degeneration preferred rats, gerbils, guinea pigs, mice, or New Zealand rabbits as experimental animals. (2) Various modeling methods for intervertebral disc degeneration have their own advantages and disadvantages; the annulus fibrosus puncture model is the most widely used model in such studies, and combined modeling methods can better simulate the process of intervertebral disc degeneration. (3) The administration routes of Chinese herbal compounds in animal models are consistent with those in humans, with oral administration being the main route. (4) Chinese herbal compounds have good therapeutic effects on intervertebral disc degeneration, often verified by imaging, behavioral, molecular biological, and histological methods.
1. Introduction
Lumbar intervertebral disc degeneration involves degenerative changes in the intervertebral disc and its surrounding structures, leading to low back pain and motor dysfunction, which severely affect patients' quality of life. The pathogenesis of intervertebral disc degeneration is complex, and Chinese herbal compounds, as multi-herb formulations, exert multi-target effects and regulate cellular and molecular processes at multiple biological levels, potentially offering broader and more effective therapeutic benefits [1]. Some researchers have validated the efficacy of Chinese herbal compounds through clinical observations, including overall response rates, but the modern pharmacological mechanisms require further investigation [2].
To explore the mechanisms of Chinese herbal compounds in treating lumbar disc degeneration, numerous animal experiments have been reported. The selection of an appropriate animal model is crucial, as it should faithfully mimic the pathological processes and clinical features of human disease. Various animal models have been established, including natural aging, mechanical injury, and abnormal stress models, each with unique advantages and limitations [3]. Researchers must weigh differences from human discs, cost-effectiveness, and experimental complexity when choosing and using these models.
Loading authentic research manuscript (Pages 1ā5)...
XIE Ziying, LI Songbo, LI Jianwen, YIN Yuchao, ZHENG Baichuan, HU Chengshang (2026). Animal experimental study on the treatment of lumbar intervertebral disc degeneration with Chinese herbal compound: species selection, modeling method and drug administration. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21257
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What animal models are commonly used in studies of Chinese herbal compounds for lumbar disc degeneration?
Commonly used animal models include rats, gerbils, guinea pigs, mice, and New Zealand rabbits. These models are preferred due to their cost-effectiveness, ease of handling, and relevance to human disc degeneration.
What is the most widely used modeling method for lumbar disc degeneration in animal experiments?
The annulus fibrosus puncture model is the most widely used method. It involves puncturing the annulus fibrosus to induce disc degeneration, and it can be combined with other methods to better simulate the disease process.
How are Chinese herbal compounds administered in animal experiments?
The administration routes in animal models are consistent with human use, with oral administration being the most common. Other routes include transdermal, rectal, and injection methods, depending on the study design.
What outcome measures are used to evaluate the efficacy of Chinese herbal compounds in animal models?
Efficacy is typically evaluated using imaging (e.g., MRI), behavioral tests (e.g., pain assessment), molecular biology (e.g., gene expression), and histological analyses (e.g., disc structure).
Why is it important to review animal experimental studies on Chinese herbal compounds for lumbar disc degeneration?
This review provides a comprehensive summary of animal model selection, modeling methods, and administration routes, which helps standardize experimental designs and improve the translational value of preclinical studies.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.